Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways.

Majem B, Parrilla A, Jiménez C, Suárez-Cabrera L, Barber M, Marín A, Castellví J, Tamayo G, Moreno-Bueno G, Ponce J, Matias-Guiu X, Alameda F, Romero I, Sánchez JL, Pérez-Benavente A, Moran S, Esteller M, Reventós J, Rigau M, Gil-Moreno A, Segura MF, Santamaría A.

Oncogene. 2019 Jul 5. doi: 10.1038/s41388-019-0860-0. [Epub ahead of print]

PMID:
31278368
2.

Defining a mutational signature for endometrial cancer screening and early detection.

Costas L, Palomero L, Benavente Y, Guardiola M, Frias-Gomez J, Pavón MÁ, Climent M, Martinez JM, Barahona M, Salinas M, Pineda M, Bianchi I, Reventós J, Capellà G, Diaz M, Vidal A, Piulats JM, Ponce J, Brunet J, Bosch FX, Matias-Guiu X, Alemany L, de Sanjosé S, Aytés Á; Screenwide Team.

Cancer Epidemiol. 2019 Jun 22;61:129-132. doi: 10.1016/j.canep.2019.06.003. [Epub ahead of print]

PMID:
31238232
3.

EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.

Roman-Canal B, Tarragona J, Moiola CP, Gatius S, Bonnin S, Ruiz-Miró M, Sierra JE, Rufas M, González E, Porcel JM, Gil-Moreno A, Falcón-Pérez JM, Ponomarenko J, Matias-Guiu X, Colas E.

J Transl Med. 2019 Jun 20;17(1):208. doi: 10.1186/s12967-019-1954-8.

4.

EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer.

Roman-Canal B, Moiola CP, Gatius S, Bonnin S, Ruiz-Miró M, González E, González-Tallada X, Llordella I, Hernández I, Porcel JM, Gil-Moreno A, Falcón-Pérez JM, Ponomarenko J, Matias-Guiu X, Colas E.

Cancers (Basel). 2019 Jun 18;11(6). pii: E839. doi: 10.3390/cancers11060839.

5.

New perspectives on screening and early detection of endometrial cancer.

Costas L, Frias-Gomez J, Guardiola M, Benavente Y, Pineda M, Pavón MÁ, Martínez JM, Climent M, Barahona M, Canet J, Paytubi S, Salinas M, Palomero L, Bianchi I, Reventós J, Capellà G, Diaz M, Vidal A, Piulats JM, Aytés Á, Ponce J, Brunet J, Bosch FX, Matias-Guiu X, Alemany L, de Sanjosé S; Screenwide Team.

Int J Cancer. 2019 Jun 14. doi: 10.1002/ijc.32514. [Epub ahead of print] Review.

PMID:
31199503
6.

The ectonucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in human endometrium: a novel marker of basal stroma and mesenchymal stem cells.

Trapero C, Vidal A, Rodríguez-Martínez A, Sévigny J, Ponce J, Coroleu B, Matias-Guiu X, Martín-Satué M.

Purinergic Signal. 2019 Jun;15(2):225-236. doi: 10.1007/s11302-019-09656-3. Epub 2019 May 23.

PMID:
31123897
7.

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study.

Visser NCM, van der Putten LJM, van Egerschot A, Van de Vijver KK, Santacana M, Bronsert P, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Krakstad C, Tangen IL, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Hausnerova J, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Trovik J, Amant F, Massuger LFAG, Bulten J, Pijnenborg JMA.

Hum Pathol. 2019 Jul;89:90-98. doi: 10.1016/j.humpath.2019.04.014. Epub 2019 May 3.

PMID:
31054899
8.

Poor outcome in hypoxic endometrial carcinoma is related to vascular density.

Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Küsters-Vandevelde HVN, Matias-Guiu X, Amant F; ENITEC-consortium, Massuger LFAG, Bussink J, Pijnenborg JMA.

Br J Cancer. 2019 May;120(11):1037-1044. doi: 10.1038/s41416-019-0461-2. Epub 2019 Apr 23.

PMID:
31011231
9.

Magnetic detection of sentinel lymph node in papillary thyroid carcinoma: The MAGIC-PAT study results.

Baena Fustegueras JA, González FH, Calderó SG, de la Fuente Juárez MC, López SR, Riu FR, Petit NM, Álvarez PM, Torelló AL, Matias-Guiu X, Olsina Kissler JJ.

Eur J Surg Oncol. 2019 Jul;45(7):1175-1181. doi: 10.1016/j.ejso.2019.03.017. Epub 2019 Mar 15.

PMID:
30905393
10.

Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.

Felip I, Moiola CP, Megino-Luque C, Lopez-Gil C, Cabrera S, Solé-Sánchez S, Muñoz-Guardiola P, Megias-Roda E, Pérez-Montoyo H, Alfon J, Yeste-Velasco M, Santacana M, Dolcet X, Reques A, Oaknin A, Rodríguez-Freixinos V, Lizcano JM, Domènech C, Gil-Moreno A, Matias-Guiu X, Colas E, Eritja N.

Gynecol Oncol. 2019 May;153(2):425-435. doi: 10.1016/j.ygyno.2019.03.002. Epub 2019 Mar 7.

PMID:
30853360
11.

Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.

Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I, Ilieva KM, Cantelli G, Karagiannis P, Mele S, Lam H, Josephs DH, Matias-Guiu X, Marti RM, Nestle FO, Orgaz JL, Malanchi I, Fruhwirth GO, Karagiannis SN, Sanz-Moreno V.

Cell. 2019 Feb 7;176(4):757-774.e23. doi: 10.1016/j.cell.2018.12.038. Epub 2019 Jan 31.

12.

Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma.

Cuevas D, Valls J, Gatius S, Roman-Canal B, Estaran E, Dorca E, Santacana M, Vaquero M, Eritja N, Velasco A, Matias-Guiu X.

Virchows Arch. 2019 May;474(5):585-598. doi: 10.1007/s00428-018-02516-2. Epub 2019 Feb 1.

PMID:
30710169
13.

Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.

Mariscal J, Fernandez-Puente P, Calamia V, Abalo A, Santacana M, Matias-Guiu X, Lopez-Lopez R, Gil-Moreno A, Alonso-Alconada L, Abal M.

J Proteome Res. 2019 Mar 1;18(3):1043-1053. doi: 10.1021/acs.jproteome.8b00750. Epub 2019 Jan 11.

PMID:
30585730
14.

[2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary].

Matías-Guiu X, Fusté V, Iglesias L, Balañá C, Concha Á, de la Cruz-Merino L, Nieto B, Pané M, Sanz J, Losa F.

Rev Esp Patol. 2019 Jan - Mar;52(1):33-44. doi: 10.1016/j.patol.2018.08.002. Epub 2018 Oct 10. Review. Spanish.

PMID:
30583830
15.

Multifocal granular cell tumour of the biliary tree.

Vilardell F, Pardina M, Olsina JJ, Matias-Guiu X.

BMJ Case Rep. 2018 Nov 28;11(1). pii: e226352. doi: 10.1136/bcr-2018-226352.

PMID:
30567101
16.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S93-S113. doi: 10.1097/PGP.0000000000000524.

17.

Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites.

Stewart CJR, Crum CP, McCluggage WG, Park KJ, Rutgers JK, Oliva E, Malpica A, Parkash V, Matias-Guiu X, Ronnett BM.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S75-S92. doi: 10.1097/PGP.0000000000000553. Review.

18.

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.

Soslow RA, Tornos C, Park KJ, Malpica A, Matias-Guiu X, Oliva E, Parkash V, Carlson J, McCluggage WG, Gilks CB.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S64-S74. doi: 10.1097/PGP.0000000000000518. Review.

19.

High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.

Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S40-S63. doi: 10.1097/PGP.0000000000000491. Review.

20.

Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.

Rabban JT, Gilks CB, Malpica A, Matias-Guiu X, Mittal K, Mutter GL, Oliva E, Parkash V, Ronnett BM, Staats P, Stewart CJR, McCluggage WG.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S25-S39. doi: 10.1097/PGP.0000000000000512.

21.

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

Malpica A, Euscher ED, Hecht JL, Ali-Fehmi R, Quick CM, Singh N, Horn LC, Alvarado-Cabrero I, Matias-Guiu X, Hirschowitz L, Duggan M, Ordi J, Parkash V, Mikami Y, Ruhul Quddus M, Zaino R, Staebler A, Zaloudek C, McCluggage WG, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S9-S24. doi: 10.1097/PGP.0000000000000552.

22.

Current Practices in the Processing, Diagnosis, and Reporting of Endometrial Carcinoma: Results of a Web-based Survey by the International Society of Gynecological Pathologists (ISGyP).

Parkash V, Matias-Guiu X, Oliva E, Malpica A, McCluggage WG.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S3-S8. doi: 10.1097/PGP.0000000000000515.

23.

The International Society of Gynecological Pathologists (ISGyP) Endometrial Carcinoma Project.

McCluggage WG, Malpica A, Matias-Guiu X, Oliva E, Parkash V.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S1-S2. doi: 10.1097/PGP.0000000000000495. No abstract available.

24.

Digital quantification of KI-67 in breast cancer.

Del Rosario Taco Sanchez M, Soler-Monsó T, Petit A, Azcarate J, Lasheras A, Artal C, Gil M, Falo C, Pla MJ, Matias-Guiu X.

Virchows Arch. 2019 Feb;474(2):169-176. doi: 10.1007/s00428-018-2481-3. Epub 2018 Nov 21.

PMID:
30465110
25.

CTCs-derived xenograft development in a triple negative breast cancer case.

Pereira-Veiga T, Abreu M, Robledo D, Matias-Guiu X, Santacana M, Sánchez L, Cueva J, Palacios P, Abdulkader I, López-López R, Muinelo-Romay L, Costa C.

Int J Cancer. 2019 May 1;144(9):2254-2265. doi: 10.1002/ijc.32001. Epub 2018 Dec 16.

PMID:
30450632
26.

Can the classification of low-grade endometrial stromal tumors still be improved?

Matias-Guiu X, Davidson B, Lax SF.

Virchows Arch. 2018 Dec;473(6):663-664. doi: 10.1007/s00428-018-2474-2. Epub 2018 Oct 26. No abstract available.

PMID:
30367239
27.

Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures.

Castellsagué E, Li R, Aligue R, González S, Sanz J, Martin E, Velasco À, Capellá G, Stewart CJR, Vidal A, Majewski J, Rivera B, Polak P, Matias-Guiu X, Brunet J, Foulkes WD.

Hum Mutat. 2019 Jan;40(1):36-41. doi: 10.1002/humu.23676. Epub 2018 Nov 20.

PMID:
30362666
28.

Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis.

Dosil MA, Navaridas R, Mirantes C, Tarragona J, Eritja N, Felip I, Urdanibia I, Megino C, Domingo M, Santacana M, Gatius S, Piñol C, Barceló C, Maiques O, Macià A, Velasco A, Vaquero M, Matias-Guiu X, Dolcet X.

J Pathol. 2019 Jan;247(1):72-85. doi: 10.1002/path.5168. Epub 2018 Nov 27.

PMID:
30206933
29.

Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis.

Karpathiou G, Matias-Guiu X, Mobarki M, Vermesch C, Stachowicz ML, Chauleur C, Peoc'h M.

Hum Pathol. 2019 Mar;85:309-312. doi: 10.1016/j.humpath.2018.08.015. Epub 2018 Aug 30.

PMID:
30171991
30.

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.

Versluis M, Plat A, de Bruyn M, Matias-Guiu X, Trovic J, Krakstad C, Nijman HW, Bosse T, de Bock GH, Hollema H.

Virchows Arch. 2018 Nov;473(5):591-598. doi: 10.1007/s00428-018-2444-8. Epub 2018 Aug 23.

PMID:
30140948
31.

Patient-Derived Xenograft Models for Endometrial Cancer Research.

Moiola CP, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, Fonnes T, Vidal A, Villanueva A, Matias-Guiu X, Krakstad C, Amant F, Gil-Moreno A, Colas E.

Int J Mol Sci. 2018 Aug 17;19(8). pii: E2431. doi: 10.3390/ijms19082431. Review.

32.

[Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].

Garrido P, Aldaz A, Calleja MÁ, de Álava E, Lamas MJ, Martín M, Matías-Guiu X, Palacios J, Vera R.

Rev Esp Patol. 2018 Jul - Sep;51(3):154-159. doi: 10.1016/j.patol.2017.10.003. Epub 2017 Nov 15. Spanish.

PMID:
30012308
33.

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.

Losa F, Iglesias L, Pané M, Sanz J, Nieto B, Fusté V, de la Cruz-Merino L, Concha Á, Balañá C, Matías-Guiu X.

Clin Transl Oncol. 2018 Nov;20(11):1361-1372. doi: 10.1007/s12094-018-1899-z. Epub 2018 May 28. Review.

34.

Early evolutionary divergence between papillary and anaplastic thyroid cancers.

Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratù G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J.

Ann Oncol. 2018 Jun 1;29(6):1454-1460. doi: 10.1093/annonc/mdy123.

PMID:
29648575
35.

[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

Oaknin A, Guarch R, Barretina P, Hardisson D, González-Martín A, Matías-Guiu X, Pérez-Fidalgo A, Vieites B, Romero I, Palacios J.

Rev Esp Patol. 2018 Apr - Jun;51(2):84-96. doi: 10.1016/j.patol.2017.11.002. Epub 2018 Jan 17. Spanish.

PMID:
29602379
36.

International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.

Cho KR, Cooper K, Croce S, Djordevic B, Herrington S, Howitt B, Hui P, Ip P, Koebel M, Lax S, Quade BJ, Shaw P, Vidal A, Yemelyanova A, Clarke B, Hedrick Ellenson L, Longacre TA, Shih IM, McCluggage WG, Malpica A, Oliva E, Parkash V, Matias-Guiu X.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S114-S122. doi: 10.1097/PGP.0000000000000496.

37.

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.

Bosse T, Nout RA, McAlpine JN, McConechy MK, Britton H, Hussein YR, Gonzalez C, Ganesan R, Steele JC, Harrison BT, Oliva E, Vidal A, Matias-Guiu X, Abu-Rustum NR, Levine DA, Gilks CB, Soslow RA.

Am J Surg Pathol. 2018 May;42(5):561-568. doi: 10.1097/PAS.0000000000001020.

38.

ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.

Alsina-Sanchís E, García-Ibáñez Y, Figueiredo AM, Riera-Domingo C, Figueras A, Matias-Guiu X, Casanovas O, Botella LM, Pujana MA, Riera-Mestre A, Graupera M, Viñals F.

Arterioscler Thromb Vasc Biol. 2018 May;38(5):1216-1229. doi: 10.1161/ATVBAHA.118.310760. Epub 2018 Feb 15.

39.

Correction to: SEOM clinical guidelines for endometrial cancer (2017).

Santaballa A, Matías-Guiu X, Redondo A, Carballo N, Gil M, Gómez C, Gorostidi M, Gutierrez M, Gónzalez-Martín A.

Clin Transl Oncol. 2018 Apr;20(4):559-560. doi: 10.1007/s12094-018-1842-3.

PMID:
29417438
40.

T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1.

Maiques O, Barceló C, Panosa A, Pijuan J, Orgaz JL, Rodriguez-Hernandez I, Matas-Nadal C, Tell G, Vilella R, Fabra A, Puig S, Sanz-Moreno V, Matias-Guiu X, Canti C, Herreros J, Marti RM, Macià A.

Pigment Cell Melanoma Res. 2018 Jul;31(4):484-495. doi: 10.1111/pcmr.12690. Epub 2018 Feb 18.

PMID:
29385656
41.

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.

van der Putten LJM, Visser NCM, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Trovik J, Kopperud RK, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Salvesen HB, Werner HMJ, Amant F, Massuger LFAG, Pijnenborg JMA.

Int J Gynecol Cancer. 2018 Mar;28(3):514-523. doi: 10.1097/IGC.0000000000001187.

PMID:
29324536
42.

Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients.

Eritja N, Jové M, Fasmer KE, Gatius S, Portero-Otin M, Trovik J, Krakstad C, Sol J, Pamplona R, Haldorsen IS, Matias-Guiu X.

Oncotarget. 2017 Nov 20;8(65):109018-109026. doi: 10.18632/oncotarget.22558. eCollection 2017 Dec 12.

43.

Circulating tumor cells (CTCs) and cytokeratin 19 (CK19) mRNA as prognostic factors in heavily pretreated patients with metastatic breast cancer.

Morales S, Velasco A, Gasol A, Córdoba F, Vidal J, Serrate A, Valls J, Samame JC, Gisbert R, Moral D, Llombart-Cussac A, Salud A, Matias-Guiu X.

Cancer Treat Res Commun. 2018;16:13-17. doi: 10.1016/j.ctarc.2018.04.003. Epub 2018 Apr 25.

PMID:
31298997
44.

Characterization of ecto-nucleotidases in human oviducts with an improved approach simultaneously identifying protein expression and in situ enzyme activity.

Villamonte ML, Torrejón-Escribano B, Rodríguez-Martínez A, Trapero C, Vidal A, Gómez de Aranda I, Sévigny J, Matías-Guiu X, Martín-Satué M.

Histochem Cell Biol. 2018 Mar;149(3):269-276. doi: 10.1007/s00418-017-1627-8. Epub 2017 Dec 22.

PMID:
29273916
45.

Endometriosis-associated ovarian neoplasia.

Matias-Guiu X, Stewart CJR.

Pathology. 2018 Feb;50(2):190-204. doi: 10.1016/j.pathol.2017.10.006. Epub 2017 Dec 11. Review.

PMID:
29241974
46.

SEOM clinical guidelines for endometrial cancer (2017).

Santaballa A, Matías-Guiu X, Redondo A, Carballo N, Gil M, Gómez C, Gorostidi M, Gutierrez M, Gónzalez-Martín A.

Clin Transl Oncol. 2018 Jan;20(1):29-37. doi: 10.1007/s12094-017-1809-9. Epub 2017 Dec 13. Erratum in: Clin Transl Oncol. 2018 Feb 7;:.

47.

The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.

Goebel EA, Vidal A, Matias-Guiu X, Blake Gilks C.

Virchows Arch. 2018 Jun;472(6):885-896. doi: 10.1007/s00428-017-2279-8. Epub 2017 Dec 12. Review.

PMID:
29234950
48.

Analysis of the ectoenzymes ADA, ALP, ENPP1, and ENPP3, in the contents of ovarian endometriomas as candidate biomarkers of endometriosis.

Trapero C, Jover L, Fernández-Montolí ME, García-Tejedor A, Vidal A, Gómez de Aranda I, Ponce J, Matias-Guiu X, Martín-Satué M.

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12794. Epub 2017 Nov 30.

PMID:
29194839
49.

Advances in endometrial cancer protein biomarkers for use in the clinic.

Martinez-Garcia E, Lopez-Gil C, Campoy I, Vallve J, Coll E, Cabrera S, Ramon Y Cajal S, Matias-Guiu X, Van Oostrum J, Reventos J, Gil-Moreno A, Colas E.

Expert Rev Proteomics. 2018 Jan;15(1):81-99. doi: 10.1080/14789450.2018.1410061. Epub 2017 Nov 30. Review.

PMID:
29183259
50.

A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination.

Figueras A, Alsina-Sanchís E, Lahiguera Á, Abreu M, Muinelo-Romay L, Moreno-Bueno G, Casanovas O, Graupera M, Matias-Guiu X, Vidal A, Villanueva A, Viñals F.

Mol Cancer Ther. 2018 Feb;17(2):532-543. doi: 10.1158/1535-7163.MCT-17-0643. Epub 2017 Nov 16.

Supplemental Content

Loading ...
Support Center